These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23449448)

  • 1. Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells.
    Kao C; Chao A; Tsai CL; Lin CY; Chuang WC; Chen HW; Yen TC; Wang TH; Lai CH; Wang HS
    Cell Death Dis; 2013 Feb; 4(2):e512. PubMed ID: 23449448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.
    Selimovic D; Porzig BB; El-Khattouti A; Badura HE; Ahmad M; Ghanjati F; Santourlidis S; Haikel Y; Hassan M
    Cell Signal; 2013 Jan; 25(1):308-18. PubMed ID: 23079083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer.
    Uddin S; Ahmed M; Hussain AR; Jehan Z; Al-Dayel F; Munkarah A; Bavi P; Al-Kuraya KS
    Lab Invest; 2009 Oct; 89(10):1115-27. PubMed ID: 19636294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
    Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
    Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
    Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
    Kawabata S; Gills JJ; Mercado-Matos JR; Lopiccolo J; Wilson W; Hollander MC; Dennis PA
    Cell Death Dis; 2012 Jul; 3(7):e353. PubMed ID: 22825471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
    Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
    Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CIP2A in the antitumor effect of bortezomib in colon cancer.
    Ding Y; Wang Y; Ju S; Wu X; Zhu W; Shi F; Mao L
    Mol Med Rep; 2014 Jul; 10(1):387-92. PubMed ID: 24789441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.
    Huang C; Lu X; Tong L; Wang J; Zhang W; Jiang B; Yang R
    J Neuroinflammation; 2015 Oct; 12():189. PubMed ID: 26467650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune mechanism of the antitumor effects generated by bortezomib.
    Chang CL; Hsu YT; Wu CC; Yang YC; Wang C; Wu TC; Hung CF
    J Immunol; 2012 Sep; 189(6):3209-20. PubMed ID: 22896634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.
    Vangala JR; Dudem S; Jain N; Kalivendi SV
    J Biol Chem; 2014 May; 289(18):12612-22. PubMed ID: 24627483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
    Kim SY; Song X; Zhang L; Bartlett DL; Lee YJ
    Biochem Pharmacol; 2014 Mar; 88(2):178-88. PubMed ID: 24486574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib pre-treatment prolongs interferon-alpha-induced STAT1 phosphorylation in melanoma cells.
    Lesinski GB; Benninger K; Kreiner M; Quimper M; Young G; Carson WE
    Cancer Immunol Immunother; 2009 Dec; 58(12):2031-7. PubMed ID: 19396596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
    Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
    Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.
    Rossi A; Riccio A; Coccia M; Trotta E; La Frazia S; Santoro MG
    J Biol Chem; 2014 May; 289(18):12705-15. PubMed ID: 24619424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers.
    Radhakrishnan H; Ilm K; Walther W; Shirasawa S; Sasazuki T; Daniel PT; Gillissen B; Stein U
    Cancer Lett; 2017 Sep; 403():231-245. PubMed ID: 28649004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma.
    Baran-Marszak F; Boukhiar M; Harel S; Laguillier C; Roger C; Gressin R; Martin A; Fagard R; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Haematologica; 2010 Nov; 95(11):1865-72. PubMed ID: 20663948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
    Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
    Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of heat shock protein response enhances PS-341-mediated glioma cell death.
    Liu Y; Zheng T; Zhao S; Liu H; Han D; Zhen Y; Xu D; Wang Y; Yang H; Zhang G; Wang C; Wu J; Ye Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S421-9. PubMed ID: 21732139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells.
    Carmo CR; Lyons-Lewis J; Seckl MJ; Costa-Pereira AP
    PLoS One; 2011; 6(5):e19861. PubMed ID: 21625473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.